Actinium Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 158,140 | 0.507% |
Institutions | 9,914,104 | 31.8% |
General Public | 21,123,647 | 67.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,938,558 | US$2.8m | 3.37% | no data | |||
1,625,000 | US$2.4m | 9.86% | no data | |||
769,452 | US$1.1m | -6.89% | 15.65% | |||
686,153 | US$994.9k | 2.98% | no data | |||
602,649 | US$873.8k | -1.15% | no data | |||
453,694 | US$657.9k | 0% | no data | |||
358,812 | US$520.3k | 0% | no data | |||
253,465 | US$367.5k | 0% | 0.02% | |||
240,118 | US$348.2k | 5.1% | no data | |||
235,691 | US$341.8k | -46.6% | 2.37% | |||
215,690 | US$312.8k | 0% | no data | |||
171,180 | US$248.2k | 0% | no data | |||
166,957 | US$242.1k | 18.8% | no data | |||
160,123 | US$232.2k | 661% | no data | |||
155,000 | US$224.7k | 44.5% | no data | |||
150,170 | US$217.7k | -76.1% | no data | |||
146,103 | US$211.8k | 204% | no data | |||
142,493 | US$206.6k | 0% | 0.01% | |||
127,000 | US$184.1k | 561% | no data | |||
99,346 | US$144.1k | -41.6% | no data | |||
89,700 | US$130.1k | -30% | no data | |||
84,237 | US$122.1k | -6.07% | no data | |||
77,000 | US$111.7k | -8.3% | no data | |||
72,093 | US$104.5k | -13.7% | no data | |||
65,526 | US$95.0k | -24.2% | no data |